TY - JOUR
T1 - Kinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules
AU - Dantzler, W. H.
AU - Evans, K. K.
AU - Wright, S. H.
PY - 1995
Y1 - 1995
N2 - Kinetics of the first 15 s of para-aminohippurate (PAH) uptake across the basolateral membrane of single isolated S2 segments of rabbit proximal renal tubules and the effects of probenecid and cysteine conjugates on them were determined. For PAH uptake in control tubules, K1 (the concentration of PAH at 1/2 J(max)) was about 110 μM and J(max) (maximal rate of PAH transport) was about 6.5 pmol min-1 nl-1. In tubules preloaded with α-ketoglutarate (α-KG), thereby stimulating PAH/α-KG countertransport, J(max) doubled with little change in K(t). Probenecid cis-inhibited PAH uptake with an apparent K(i) of about 13 to 15 μM whether or not the tubules were preloaded with α- KG. High probenecid concentrations cis-inhibited PAH uptake by >98%, indicating that essentially all movement of PAH across the basolateral membrane is carrier mediated. Zwitterionic nephrotoxic cysteine conjugate, S- (1,2-dichlorovinyl)-L-cysteine (DCVC), and nontoxic cysteine conjugate, S- (2-benzothiazole)-L-cysteine (BTC) cis-inhibited PAH uptake (apparent ~86 μM for DCVC; ~37 μM for BTC) at least as effectively as their negatively charged N-acetyl derivatives (NAC-DCVC and NAC-BTC) (apparent K(i): ~310 μM for NAC-DCVC; ~35 μM for NAC-BTC). The inhibition by both DCVC and NAC- DCVC was competitive in nature. NAC-DCVC also cis-inhibited net transepithelial secretion of PAH by isolated, perused S2 segments. The presence of DCVC and NAC-DCVC, as well as PAH itself, in the bathing medium trans-stimulated the 15 s efflux of PAH across the basolateral membrane of single S2 segments with oil-filled lumens. These data indicate that these cysteine conjugates and their N-acetyl derivatives, not only interact competitively with the PAH transporter, but are transported by it.
AB - Kinetics of the first 15 s of para-aminohippurate (PAH) uptake across the basolateral membrane of single isolated S2 segments of rabbit proximal renal tubules and the effects of probenecid and cysteine conjugates on them were determined. For PAH uptake in control tubules, K1 (the concentration of PAH at 1/2 J(max)) was about 110 μM and J(max) (maximal rate of PAH transport) was about 6.5 pmol min-1 nl-1. In tubules preloaded with α-ketoglutarate (α-KG), thereby stimulating PAH/α-KG countertransport, J(max) doubled with little change in K(t). Probenecid cis-inhibited PAH uptake with an apparent K(i) of about 13 to 15 μM whether or not the tubules were preloaded with α- KG. High probenecid concentrations cis-inhibited PAH uptake by >98%, indicating that essentially all movement of PAH across the basolateral membrane is carrier mediated. Zwitterionic nephrotoxic cysteine conjugate, S- (1,2-dichlorovinyl)-L-cysteine (DCVC), and nontoxic cysteine conjugate, S- (2-benzothiazole)-L-cysteine (BTC) cis-inhibited PAH uptake (apparent ~86 μM for DCVC; ~37 μM for BTC) at least as effectively as their negatively charged N-acetyl derivatives (NAC-DCVC and NAC-BTC) (apparent K(i): ~310 μM for NAC-DCVC; ~35 μM for NAC-BTC). The inhibition by both DCVC and NAC- DCVC was competitive in nature. NAC-DCVC also cis-inhibited net transepithelial secretion of PAH by isolated, perused S2 segments. The presence of DCVC and NAC-DCVC, as well as PAH itself, in the bathing medium trans-stimulated the 15 s efflux of PAH across the basolateral membrane of single S2 segments with oil-filled lumens. These data indicate that these cysteine conjugates and their N-acetyl derivatives, not only interact competitively with the PAH transporter, but are transported by it.
UR - http://www.scopus.com/inward/record.url?scp=0028833352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028833352&partnerID=8YFLogxK
M3 - Article
C2 - 7853180
SN - 0022-3565
VL - 272
SP - 663
EP - 672
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -